The route is the destination-novel forms of application of allergen immunotherapy].

Allergen immunotherapy (AIT) is the only causal therapy of IgE-mediated allergies if allergen avoidance is not feasible. Already well established are subcutaneous (SCIT) and sublingual (SLIT) allergen application, and recently the first oral immunotherapy (OIT) for treating peanut allergy was approved. Interesting and promising new forms of allergen administration are intralymphatic (ILIT) and epicutaneous (EPIT) immunotherapy. Immunologic and clinical efficiency in terms of tolerance induction have been investigated in animal and clinical studies, including the first phase 3 studies. The findings as well as advantages and disadvantages, potential risks and challenges that still have to be addressed before routine clinical application can be envisioned will be comprehensively presented and discussed. © 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Citation

Wolfgang Pfützner. The route is the destination-novel forms of application of allergen immunotherapy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 2021 Sep;72(9):776-783

Mesh Tags

Substances

PMID: 34387710

search → result